Crystal Growth & Design
Article
Preparation of Bipyrimidine Ethyl Ester (3). Compound 1 (4.7 g,
26 mmol) and pyridine (50 mL) were added to crude ethyl 2,2-
diformylacetate (4.8 g, 33 mmol). The mixture was warmed to 70 °C
under a nitrogen atmosphere and stirred overnight. Pyridine was then
evaporated under reduced pressure to give a dark brown sticky solid.
The solid was washed multiple times with cold acetone to obtain
bipyrimidine ethylester as a beige powder in 58% yield (4.3 g, 19
mmol).
ground material and models obtained from the SCXRD
structure (after correction to account for the difference in
temperature between the two experimental techniques). Efforts
to scale up the other complexation reactions did not yield
sufficient material for PXRD or showed a mixture of phases.
CONCLUSIONS
■
1H NMR (300 MHz, CDCl3) δ = 9.52 (s, 2 H), 9.07 (d, J = 4.8 Hz,
2 H), 7.49 (t, J = 4.8 Hz, 1 H), 4.50 (q, J = 7.1 Hz, 2 H), 1.47 (t, J =
7.1 Hz, 3 H) ppm; 13C NMR (75 MHz, CD3CN) δ = 166.2, 164.7,
163.3, 159.5, 158.9, 125.1, 122.9, 62.9, 14.5; HRMS (ESI TOF) m/z
[M + H]+ Calcd for C11H11N4O2: 231.0882. Found: 231.0878; Anal.
Calcd for C11H10N4O2: C, 57.39; H, 4.38; N, 24.34. Found: C, 57.11;
H, 4.37; N, 23.96; melting point range: 146−149 °C.
Preparation of Bipyrimidine Carboxylic Acid (4). To a flask
containing 3 (4.3 g, 19 mmol) was added sodium hydroxide (5.0 g,
125 mmol) and water (50 mL). The mixture was stirred at room
temperature for 3 h and acidified with conc. HCl until a white
precipitate formed. The solid was filtered off and washed with cold
water to give bipyrimidine carboxylic acid 4 as a white powder in 89%
yield (3.5 g, 17 mmol).
In summary, we have developed the synthesis of 5-substituted
bipyrimidines. To demonstrate the utility of these function-
alized compounds, four new derivatives were synthesized and
used as ligands. When combined with silver(I) salts, these
bipyrimidine ligands rapidly bind to the metal ion and
crystallize into coordination polymers with diverse 1-D chain
structures. This new family of bridging ligands is promising for
the development of coordination polymers. We are now
investigating the coordination chemistry of related ligands to
form complex metallosupramolecular assemblies.
EXPERIMENTAL SECTION
■
1H NMR (400 MHz, DMSO-d6) δ = 9.39 (s, 2 H), 9.05 (d, J = 4.8
Hz, 2 H), 7.70 (t, J = 4.8 Hz, 1 H) ppm; 13C NMR (101 MHz,
DMSO-d6) δ = 164.8, 164.6, 162.0, 158.6, 158.0, 124.3, 122.2 ppm;
HRMS (TOF ES-, m/z) Calcd for C9H5N4O2 [M − H]−: 201.0413.
Found: 201.0415; Anal. Calcd for C9H7N4O2.5 (M+0.5H2O): C,
51.19; H, 3.34; N, 26.53. Found: C, 51.17; H, 3.36; N, 26.24; melting
point > 260 °C.
General Remarks. All reagents were purchased from Sigma-
Aldrich or AK Scientific and used without further purification. 4-
Tritylaniline was synthesized according to a literature procedure.31 1H
and 13C NMR spectra were recorded on a Bruker AV-300 or AV-400
spectrometer and referenced to residual solvent signals. 13C NMR
spectra were recorded using a proton decoupled pulse sequence.
Electrospray ionization mass spectra (ESI-MS) were obtained on a
Waters/Micromass LCT-TOF instrument. Melting points were
recorded on a Stanford Research Systems Digimelt. Elemental analyses
were performed at the UBC Microanalytical Services Laboratory.
PXRD patterns were collected on a Bruker D8 Discover diffractometer
at room temperature. Single-crystal X-ray data were collected on a
Bruker APEX DUO diffractometer using graphite monochromated Mo
Kα radiation (λ = 0.71073 Å). All data were collected at 90 K to a
resolution of 0.77 Å. Raw frame data (including data reduction,
interframe scaling, unit cell refinement, and absorption corrections) for
all structures were processed using APEX2.32 Structures were solved
using SUPERFLIP33 and refined using full-matrix least-squares on F2
within the CRYSTALS suite.34 All non-hydrogen atoms were refined
with anisotropic displacement parameters. Hydrogen atoms were
generally visible in the Fourier difference map and were initially refined
with restraints on bond lengths and angles, after which the positions
were used as the basis for a riding model.35 The structure of
{[Ag(L3)(H2O)0.5]PF6}n is of relatively low quality and so is provided
as an indication of structural connectivity only; in this structure it was
not possible to resolve an area of diffuse electron density (believed to
arise from disordered solvent molecules), and so PLATON-SQUEEZE
was used to account for this electron density in the model.36 Individual
structures are shown in more detail in the CIFs, which have been
Synthesis of Ligands. Compound 2 was synthesized using a
reported procedure and used without further purification.37 1 had been
reported previously, but we developed a new synthesis that does not
involve the use of ammonia.38
Preparation of Bipyrimidine-amide-C6 (L1). Compound 4 (202
mg, 1.0 mmol), HOBt (203 mg, 1.5 mmol), EDCI·HCl (287 mg, 1.5
mmol), dimethylacetamide (6 mL), and hexylamine (140 μL, 1.0
mmol) were combined in a round-bottomed flask. The mixture was
sonicated until all reagents had dissolved and the solution turned
yellow. The reaction was stirred at 65 °C under a nitrogen atmosphere
for 16 h. The reaction mixture was then poured into basic water (1 g of
NaHCO3, 100 mL) and extracted three times with DCM (300 mL
total). The combined organic phase was washed with water (2 × 150
mL) and dried under reduced pressure. To the yellow oil obtained, 50
mL of water was added and left in the freezer until a white precipitate
formed. The white powder was isolated using a glass frit and washed
with water (2 × 10 mL) before being dried under reduced pressure to
obtain a white precipitate, L1 (135 mg, 0.47 mmol, 47% yield).
1H NMR (300 MHz, CDCl3) δ = 9.34 (s, 2 H), 9.06 (d, J = 4.8 Hz,
2 H), 7.49 (t, J = 4.8 Hz, 1 H), 6.27 (br. s., 1 H), 3.53 (dd, J = 6.4, 13.6
Hz, 2 H), 1.77−1.63 (m, 2 H), 1.50−1.23 (m, 6 H), 0.91 (t, J = 6.9
Hz, 3 H) ppm; 13C NMR (75 MHz, CDCl3) δ = 163.3, 163.0, 161.5,
158.1, 156.8, 127.9, 121.9, 40.4, 31.3, 29.4, 26.6, 22.4, 13.9 ppm;
HRMS (TOF ES+, m/z) Calcd for C15H19N5ONa [M + Na]+
308.1487. Found 308.1483; melting point: 130−134 °C.
Preparation of Bipyrimidine-amide-C16 (L2). To compound 4
(202 mg, 1.0 mmol), HOBt (203 mg, 1.5 mmol), and EDCI·HCl (287
mg, 1.5 mmol) in dimethylacetamide (6 mL) was added hexadecyl-
amine (241 mg, 1.0 mmol). The mixture was sonicated until all
reagents had dissolved and the solution turned a faint yellow. The
reaction was stirred at 65 °C under nitrogen for 16 h then triturated in
100 mL of basic water (1 g NaHCO3), and the white precipitate was
filtered and washed with cold water. L2 was isolated as a white powder
(345 mg, 0.82 mmol, 82% yield).
Preparation of 2-Amidinopyrimidine Acetate (1). 2-Cyanopyr-
imidine (5.0 g, 48 mmol) and ammonium acetate (7.0 g, 91 mmol)
were mixed in 50 mL of methanol and heated to 80 °C for 16 h. After
being cooled down to room temperature, the yellow solution
containing a pale precipitate was taken to dryness under reduced
pressure. The solid was washed with a small amount of cold methanol
to give pure 2-amidinopyrimidine acetate as a white solid (3.5 g, 19
mmol, 40% yield).
1H NMR (300 MHz, CDCl3) δ = 9.34 (s, 2 H), 9.06 (d, J = 4.9 Hz,
2 H), 7.49 (t, J = 4.9 Hz, 1 H), 6.26 (t, J = 4.9 Hz, 1 H), 3.53 (dd, J =
7.2, 13.1 Hz, 2 H), 1.73−1.66 (m, 2 H), 1.38 (br. s., 2 H), 1.26 (br. m.,
24 H), 0.89 (t, J = 6.9 Hz, 3 H) ppm; 13C NMR (75 MHz, CD3OH) δ
= 163.2, 162.8, 160.0, 159.4, 132.4, 123.7, 40.9, 33.2, 30.94, 30.91,
30.8, 30.64, 30.62, 30.4, 28.8, 27.6, 23.9, 14.6 ppm; HRMS (TOF ES+,
m/z) Calcd for C25H39N5ONa [M + Na]+ 448.3052, found 448.3058;
melting point: dec 197 °C.
1H NMR (400 MHz, D2O) δ = 8.95 (d, J = 5.0 Hz, 2 H), 7.72 (t, J
= 5.0 Hz, 1 H), 1.84 (s, 3 H) ppm; 13C NMR (101 MHz, D2O) δ =
181.4, 159.8, 158.3, 152.3, 124.8, 23.4 ppm; HRMS (ESI TOF) m/z
[M − CH3COO]+ Calcd for C5H7N4 123.0671. Found 123.0673;
Anal. calcd for C7H10N4O2: C, 46.15; H, 5.53; N, 30.75. Found: C,
46.48; H, 5.54; N, 30.71; melting point: dec > 205 °C.
Preparation of Bipyrimidine-amide-t-butylphenyl (L3). 4-tert-
Butylaniline (160 μL, 1.0 mmol) was added to a suspension of 4
(202 mg, 1.0 mmol), HOBt (203 mg, 1.5 mmol) and EDCI·HCl (287
E
Cryst. Growth Des. XXXX, XXX, XXX−XXX